Breaking News Instant updates and real-time market news.

ALBO

Albireo Pharma

$17.05

0.1 (0.59%)

, BNCN

BNC Bancorp

08:30
06/19/17
06/19
08:30
06/19/17
08:30

Twelve option delistings on June 19th

Option delistings effective June 19th include Aixtron SE (ADS) (AIXNY), Albireo (ALBO), AVG Technologies NV (AVGTF), BNC Bancorp (BNCN), AM Castle and Company Inc (CASL), Eca Marcellus (ECT), First Defiance Financial (FDEF), UBS Natural Gas Subindex (GAZ), Immune Design (IMDZ), Lifetime Brands (LCUT), Luxottica (LUX), and Yahoo (YHOO).

ALBO

Albireo Pharma

$17.05

0.1 (0.59%)

BNCN

BNC Bancorp

CASL

Castle Dental Centers

ECT

ECA Marcellus

$2.15

0.1 (4.88%)

FDEF

First Defiance Financial

$53.92

-0.89 (-1.62%)

IMDZ

Immune Design

$7.20

0.05 (0.70%)

LCUT

Lifetime Brands

$17.95

-0.25 (-1.37%)

LUX

Luxottica

YHOO

Tag AABA

  • 21

    Jun

  • 18

    Sep

  • 28

    Sep

ALBO Albireo Pharma
$17.05

0.1 (0.59%)

01/25/17
WBLR
01/25/17
INITIATION
WBLR
Outperform
Albireo Pharma initiated with an Outperform at William Blair
William Blair analyst Y. Katherine Xu started Albireo Pharma with an Outperform rating. The company's A4250 has a "strong chance of success" in becoming the standard of care in progressive familial intrahepatic cholestasis, Xu tells investors in a research note. She derives a fair value for Albireo shares of $70 at the end of 2017. The stock closed yesterday at $18.50.
02/16/17
LTCO
02/16/17
INITIATION
Target $40
LTCO
Buy
Albireo Pharma initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Matt Kaplan started Albireo Pharma with a Buy rating and $40 price target. The analyst views Albireo's lead product as A4250, which is currently in Phase 2 development for treatment of cholestatic liver diseases in pediatric patients. Kaplan says the company has a "solid" pipeline of programs with multiple catalysts and projected total peak sales of over $975M.
02/16/17
02/16/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Salesforce (CRM) initiated with a Hold at Needham by analyst Scott Berg, who cites decelerating organic revenue growth, a looming sales reorganization, and an operating model not profitable enough at its revenue to drive valuation higher. 2. BioCryst (BCRX) initiated with a Buy at Ladenburg by analyst Christopher James, who thinks the company is poised to become a leading oral drug rare disease company. 3. Seaport Global analyst Josh Sullivan started CACI (CACI) International with a Buy rating and $140 price target. The company has broad exposure to trends in fiscal/defense spending, the analyst contends. 4. Citi analyst Walter Pritchard started OpenText (OTEX) with a Neutral rating and $36 price target, stating that the current valuation already reflects the potential of the ECD acquisition. 5. Albireo Pharma (ALBO) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BNCN BNC Bancorp

11/16/16
11/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Intuit (INTU) assumed with a Hold at Evercore ISI. 2. BNC Bancorp (BNCN) initiated with an Overweight at Piper Jaffray. 3. Cooper Tire (CTB) coverage resumed with an Overweight at KeyBanc. 4. Lithia Motors (LAD) coverage resumed with an Overweight at KeyBanc. 5. Nielsen (NLSN) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/22/16
SDLR
11/22/16
DOWNGRADE
Target $32
SDLR
Hold
BNC Bancorp downgraded to Hold from Buy at Sandler O'Neill
Sandler O'Neill analyst Stephen Scouten downgraded BNC Bancorp to Hold citing the recent strong move in shares and raised its price target to $32.
11/29/16
KBWI
11/29/16
DOWNGRADE
Target $32
KBWI
Market Perform
BNC Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Brady Gailey downgraded BNC Bancorp to Market Perform citing valuation with the stock up 23% since November 8. The analyst raised his price target for the shares to $32 from $26.50.
01/25/17
SPHN
01/25/17
DOWNGRADE
SPHN
Equal Weight
BNC Bancorp downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Tyler Stafford downgraded BNC Bancorp (BNCN) to Equal Weight from Overweight after the company agreed to merge with and into Pinnacle Financial Partners (PNFP) in an all-stock transaction.
CASL Castle Dental Centers

ECT ECA Marcellus
$2.15

0.1 (4.88%)

FDEF First Defiance Financial
$53.92

-0.89 (-1.62%)

IMDZ Immune Design
$7.20

0.05 (0.70%)

LCUT Lifetime Brands
$17.95

-0.25 (-1.37%)

12/15/16
SIDC
12/15/16
DOWNGRADE
Target $19
SIDC
Neutral
Lifetime Brands downgraded to Neutral from Buy at Sidoti
Sidoti analyst Frank Camma downgraded Lifetime Brands to Neutral citing valuation and the "tepid" retail environment. The analyst keeps a $19 price target for the shares.
02/10/17
SIDC
02/10/17
UPGRADE
Target $19
SIDC
Buy
Lifetime Brands upgraded to Buy from Neutral at Sidoti
Sidoti analyst Frank Camma upgraded Lifetime Brands to Buy from Neutral saying that its valuation has become compelling as its restructuring and acquisitions are poised to drive earnings growth. The analyst keeps a $19 price target on Lifetime shares.
03/16/17
SIDC
03/16/17
DOWNGRADE
Target $19
SIDC
Neutral
Lifetime Brands downgraded to Neutral from Buy at Sidoti
Sidoti analyst Frank Camma downgraded Lifetime Brands to Neutral with the stock above his unchanged price target of $13 following Mill Road Capital's offer.
05/26/17
SIDC
05/26/17
UPGRADE
SIDC
Buy
Lifetime Brands upgraded to Buy from Neutral at Sidoti
LUX Luxottica

09/29/16
BOFA
09/29/16
NO CHANGE
Target $41
BOFA
Underperform
Luxottica faces significant headwinds, added to Q4 Top Ideas at BofA/Merrill
BofA/Merrill analyst Ashley Wallace expects weak retail and wholesale sales trends from Luxottica's Q3 earnings report October 24. The analyst expects earnings downgrades to follow and for multiple pressure. Wallace remains concerned about Luxottica reduced brand momentum, increased competition, the highly promotional business environment, and loss of control over distribution. She reiterates her Underperform rating and $41 price target and added Luxottica to BofA/Merrill's Q4 EMEA Top Ideas list.
01/05/17
SOCG
01/05/17
DOWNGRADE
SOCG
Hold
Luxottica downgraded to Hold from Buy at Societe Generale
01/17/17
GSCO
01/17/17
UPGRADE
GSCO
Neutral
Luxottica upgraded to Neutral from Sell at Goldman
Goldman analyst Jamie Bajwa upgraded Luxottica from Sell to Neutral on the belief that the announcement of its proposed merger with Essilor increases the M&A expectations for Luxottica. The firm's target on Luxottica was raised to EUR 57.8 from EUR 40.5.
01/27/17
HSBC
01/27/17
UPGRADE
HSBC
Buy
Luxottica upgraded to Buy from Hold at HSBC
YHOO Tag AABA

04/19/17
OPCO
04/19/17
NO CHANGE
Target $57
OPCO
Outperform
Yahoo price target raised to $57 from $52 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Yahoo to $57 from $52 after the company reported Q1 earnings. The analyst reiterates an Outperform rating on the shares.
04/21/17
OPCO
04/21/17
NO CHANGE
OPCO
Perform
Verizon responding to wireless competition, says Oppenheimer
Oppenheimer analyst Timothy Horan expects Verizon's (VZ) equipment revenue in Q4 to be strong, linked to the release of the new iconic Apple (AAPL) iPhone 8. The analyst believes wireless competition will remain elevated, but Verizon is responding, and will remained focused on network quality. Further, Horan says Verizon is integrating Yahoo (YHOO)/AOL to deliver growth from programmatic ads/digital content, but this will take some time. He reiterates a Perform rating on Verizon's shares.
06/09/17
BOFA
06/09/17
NO CHANGE
Target $70
BOFA
Buy
Yahoo price target raised to $70 from $58 at BofA/Merrill
BofA/Merrill analyst Jusin Post raised Yahoo's (YHOO) price target to $70 from $58 to reflect a revised sum-of-the-parts valuation following Alibaba's (BABA) increased sales forecast and analyst Eddie Leung's revised price target on shares to $161 from $125.
06/14/17
RAJA
06/14/17
NO CHANGE
Target $72
RAJA
Yahoo price target raised to $72 from $58 at Raymond James

TODAY'S FREE FLY STORIES

ISBC

Investors Bancorp

$13.41

0.12 (0.90%)

07:49
09/19/17
09/19
07:49
09/19/17
07:49
Conference/Events
Investors Bancorp management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

TGS

Transportadora de Gas del Sur SA

$17.48

0.07 (0.40%)

07:49
09/19/17
09/19
07:49
09/19/17
07:49
Initiation
Transportadora de Gas del Sur SA initiated  »

Transportadora de Gas del…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAM

Pampa Energia S.A.

$60.93

0.2 (0.33%)

07:48
09/19/17
09/19
07:48
09/19/17
07:48
Initiation
Pampa Energia S.A. initiated  »

Pampa Energia S.A. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$37.49

0.18 (0.48%)

07:47
09/19/17
09/19
07:47
09/19/17
07:47
Hot Stocks
Breaking Hot Stocks news story on Progress Software »

Progress:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$37.49

0.18 (0.48%)

07:47
09/19/17
09/19
07:47
09/19/17
07:47
Hot Stocks
Progress Software 'values' Praesidium's ideas, welcomes input from investors »

In response to a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$56.76

0.81 (1.45%)

, AERI

Aerie Pharmaceuticals

$60.10

1.8 (3.09%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Hot Stocks
Jacobs Engineering selected by Aerie Pharmaceuticals as engineering contractor »

Jacobs Engineering Group…

JEC

Jacobs Engineering

$56.76

0.81 (1.45%)

AERI

Aerie Pharmaceuticals

$60.10

1.8 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

  • 28

    Feb

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

, AXAHY

AXA

$29.47

0.13 (0.44%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Periodicals
BNP weighing tie-up of money-management division with Axa unit, Bloomberg says »

BNP Paribas (BNPQY),…

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

AXAHY

AXA

$29.47

0.13 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHFC

Chemical Financial

$49.32

0.71 (1.46%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Downgrade
Chemical Financial rating change  »

Chemical Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSII

Quality Systems

$15.71

-0.14 (-0.88%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Initiation
Quality Systems initiated  »

Quality Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
09/19/17
09/19
07:45
09/19/17
07:45
General news
N.Y. FX Outlook »

N.Y. FX Outlook: Risk-on…

HOLI

Hollysys

$20.77

0.42 (2.06%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Conference/Events
Hollysys management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 16

    Oct

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

, AMGN

Amgen

$186.47

-1 (-0.53%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Hot Stocks
Cytokinetics doses first patient in Japan in GALACTIC-HF Phase 3 trial »

Cytokinetics announced…

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

AMGN

Amgen

$186.47

-1 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

KORS

Michael Kors

$44.65

-0.27 (-0.60%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Technical Analysis
Technical View: Michael Kors moves higher, analyst action »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Periodicals
Intel Capital invested over $1B in AI-focused companies, TechCrunch says »

Intel has invested more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 05

    Oct

PDCO

Patterson Companies

$37.94

-0.59 (-1.53%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Initiation
Patterson Companies initiated  »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$179.98

3.28 (1.86%)

, BSTI

BEST Inc

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Syndicate
BEST Inc cuts size of proposed IPO following 'tepid' response, Reuters reports »

Best Inc (BSTI), a…

BABA

Alibaba

$179.98

3.28 (1.86%)

BSTI

BEST Inc

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

FOLD

Amicus

$13.67

-0.21 (-1.51%)

07:42
09/19/17
09/19
07:42
09/19/17
07:42
Hot Stocks
Amicus granted FDA Fast Track Designation for migalastat »

Amicus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$2.73

0.1 (3.80%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Initiation
Rite Aid initiated  »

Rite Aid initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MDGL

Madrigal Pharmaceuticals

$19.80

0.99 (5.26%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Hot Stocks
Madrigal Pharmaceuticals announces positive outcome from pre-planned DSMB review »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDSO

Medidata

$75.85

-0.01 (-0.01%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Initiation
Medidata initiated  »

Medidata initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.